ArticleTurkish journal of pharmaceutical sciences2026
Missed Opportunities in Osteoporosis Prevention and Screening in Postmenopausal Women: Risk Profiles and Awareness
Article in Turkish journal of pharmaceutical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Osteoporosis (OP) is a major public health issue among postmenopausal women. Despite its high prevalence, awareness and screening practices remain insufficient. This study aims to evaluate OP-related risk factors and awareness levels among postmenopausal women. Materials and Methods: This prospective study was conducted between August 2023 and April 2024 among patients admitted to the general internal medicine outpatient clinic of a tertiary care hospital. Participants were categorized into two groups: patients with OP and patients without OP (non-OP). OP awareness was assessed using the OP awareness scale. Results: The study included 206 participants: 101 in the OP group and 105 in the non-OP group. Evaluation of risk factors (n = 20) showed no significant difference (SD) in the mean number of risk factors between the groups [OP: 7.29 (1.77), non-OP: 6.71 (1.94), Conclusion: OP prevention and its management require patient-specific strategies that include educational interventions to increase awareness and routine screening for risk factors among postmenopausal women. Pharmacists are well-positioned to identify patients’ health-related and educational needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.